Key Takeaways
- • Unilever is exploring a bid for Thorne, a South Carolina-based dietary supplements manufacturer, in a potential acquisition valued at up to $4 billion.
- • Thorne is currently owned by private equity firm L Catterton, which has placed the company on the market for sale.
- • The deal represents Unilever's continued strategic expansion into the wellness and nutrition sector, following recent acquisitions of Liquid IV (hydration sachets) and Nutrafol (hair growth supplements).
- • Thorne manufactures and sells dietary supplements including magnesium and omega-3 products, with primary distribution in the U.S. market.
Summary
Unilever is actively pursuing an acquisition of Thorne, a U.S.-based dietary supplements manufacturer, according to reporting from the Financial Times on June 26, 2026. The transaction is valued at up to $4 billion, positioning it as a significant strategic move into the fast-growing wellness and nutritional supplements category.
Thorne, headquartered in South Carolina, manufactures a broad portfolio of dietary supplements including magnesium and omega-3 products, with its customer base concentrated primarily in the United States market. The company is currently owned by L Catterton, the private equity firm that has initiated a formal sale process to divest the asset.
This potential acquisition fits squarely within Unilever's recent strategic repositioning toward health and wellness categories. The company has demonstrated clear appetite for this sector through multiple recent deals, including the acquisitions of Liquid IV, a manufacturer of hydration sachets, and Nutrafol, a hair growth supplement brand. Each of these transactions reflects management's conviction that consumer demand for targeted nutritional and wellness products represents a durable growth opportunity relative to traditional consumer staples.
The $4 billion valuation signals the premium investors currently assign to differentiated supplements businesses with established consumer brands and distribution networks. For Unilever, adding Thorne would expand its footprint in dietary supplements and deepen its portfolio of science-backed wellness offerings capable of commanding price premiums in a market increasingly focused on preventative health and nutritional optimization.
Thorne, headquartered in South Carolina, manufactures a broad portfolio of dietary supplements including magnesium and omega-3 products, with its customer base concentrated primarily in the United States market. The company is currently owned by L Catterton, the private equity firm that has initiated a formal sale process to divest the asset.
This potential acquisition fits squarely within Unilever's recent strategic repositioning toward health and wellness categories. The company has demonstrated clear appetite for this sector through multiple recent deals, including the acquisitions of Liquid IV, a manufacturer of hydration sachets, and Nutrafol, a hair growth supplement brand. Each of these transactions reflects management's conviction that consumer demand for targeted nutritional and wellness products represents a durable growth opportunity relative to traditional consumer staples.
The $4 billion valuation signals the premium investors currently assign to differentiated supplements businesses with established consumer brands and distribution networks. For Unilever, adding Thorne would expand its footprint in dietary supplements and deepen its portfolio of science-backed wellness offerings capable of commanding price premiums in a market increasingly focused on preventative health and nutritional optimization.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.